Evidence from 2100 index cases supports genome sequencing as a first-tier genetic testFen Guo, Madhuri Hegde, Xiangwen Chen‐Deutsch et al.|Genetics in Medicine|2023Cited by 23
Enhancing Fabry disease screening and diagnostic efficiency: Integration of enzyme, biomarker, and next-generation sequencing testingYinghong Pan, Madhuri Hegde, Lisa Sniderman King et al.|Molecular Genetics and Metabolism|2025Cited by 4
P389: Real-world evidence demonstrating why genome sequencing should be recommended as the first-tier genetic test*Fen Guo, Madhuri Hegde, Ruby Liu et al.|Genetics in Medicine Open|2023Cited by 0
P695: Uncertainty in interpretation of GAA variants detected through newborn screening without clinical manifestation of Pompe diseaseDona Kanavy, Catherine Rehder, Jenny Goldstein et al.|Genetics in Medicine Open|2024Cited by 0
P581: Comparison of GLA variant profile in newborn screening confirmatory testing and diagnostic testing for Fabry disease*Xiangwen Chen‐Deutsch, Madhuri Hegde, Rizwan Yousaf et al.|Genetics in Medicine Open|2024Cited by 0